Logo image of IPAR

INTERPARFUMS INC (IPAR) Stock Fundamental Analysis

NASDAQ:IPAR - Nasdaq - US4583341098 - Common Stock - Currency: USD

113.95  +1.87 (+1.67%)

Fundamental Rating

6

Overall IPAR gets a fundamental rating of 6 out of 10. We evaluated IPAR against 35 industry peers in the Personal Care Products industry. Both the health and profitability get an excellent rating, making IPAR a very profitable company, without any liquidiy or solvency issues. IPAR is not valued too expensively and it also shows a decent growth rate. With these ratings, IPAR could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

IPAR had positive earnings in the past year.
IPAR had a positive operating cash flow in the past year.
IPAR had positive earnings in each of the past 5 years.
IPAR had a positive operating cash flow in each of the past 5 years.
IPAR Yearly Net Income VS EBIT VS OCF VS FCFIPAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.31%, IPAR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
IPAR has a Return On Equity of 19.18%. This is amongst the best in the industry. IPAR outperforms 82.86% of its industry peers.
With an excellent Return On Invested Capital value of 16.62%, IPAR belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IPAR is above the industry average of 13.76%.
Industry RankSector Rank
ROA 10.31%
ROE 19.18%
ROIC 16.62%
ROA(3y)10.68%
ROA(5y)8.79%
ROE(3y)21.16%
ROE(5y)17.18%
ROIC(3y)17.76%
ROIC(5y)14.62%
IPAR Yearly ROA, ROE, ROICIPAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

IPAR has a better Profit Margin (11.03%) than 91.43% of its industry peers.
IPAR's Profit Margin has improved in the last couple of years.
IPAR has a better Operating Margin (19.21%) than 94.29% of its industry peers.
IPAR's Operating Margin has improved in the last couple of years.
IPAR has a Gross Margin of 56.34%. This is comparable to the rest of the industry: IPAR outperforms 42.86% of its industry peers.
In the last couple of years the Gross Margin of IPAR has remained more or less at the same level.
Industry RankSector Rank
OM 19.21%
PM (TTM) 11.03%
GM 56.34%
OM growth 3Y3.91%
OM growth 5Y5.52%
PM growth 3Y4.43%
PM growth 5Y6.05%
GM growth 3Y0.16%
GM growth 5Y0.24%
IPAR Yearly Profit, Operating, Gross MarginsIPAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IPAR is creating value.
IPAR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for IPAR has been increased compared to 5 years ago.
IPAR has a better debt/assets ratio than last year.
IPAR Yearly Shares OutstandingIPAR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IPAR Yearly Total Debt VS Total AssetsIPAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 5.72 indicates that IPAR is not in any danger for bankruptcy at the moment.
IPAR's Altman-Z score of 5.72 is amongst the best of the industry. IPAR outperforms 82.86% of its industry peers.
IPAR has a debt to FCF ratio of 1.61. This is a very positive value and a sign of high solvency as it would only need 1.61 years to pay back of all of its debts.
IPAR has a Debt to FCF ratio of 1.61. This is amongst the best in the industry. IPAR outperforms 88.57% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that IPAR is not too dependend on debt financing.
IPAR has a Debt to Equity ratio (0.24) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.61
Altman-Z 5.72
ROIC/WACC1.9
WACC8.74%
IPAR Yearly LT Debt VS Equity VS FCFIPAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.96 indicates that IPAR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.96, IPAR is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
A Quick Ratio of 1.69 indicates that IPAR should not have too much problems paying its short term obligations.
IPAR's Quick ratio of 1.69 is fine compared to the rest of the industry. IPAR outperforms 68.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 1.69
IPAR Yearly Current Assets VS Current LiabilitesIPAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.63% over the past year.
The Earnings Per Share has been growing by 22.27% on average over the past years. This is a very strong growth
Looking at the last year, IPAR shows a small growth in Revenue. The Revenue has grown by 7.04% in the last year.
Measured over the past years, IPAR shows a quite strong growth in Revenue. The Revenue has been growing by 15.27% on average per year.
EPS 1Y (TTM)16.63%
EPS 3Y22.78%
EPS 5Y22.27%
EPS Q2Q%-13.16%
Revenue 1Y (TTM)7.04%
Revenue growth 3Y18.2%
Revenue growth 5Y15.27%
Sales Q2Q%-2.42%

3.2 Future

Based on estimates for the next years, IPAR will show a small growth in Earnings Per Share. The EPS will grow by 5.80% on average per year.
The Revenue is expected to grow by 4.56% on average over the next years.
EPS Next Y5.32%
EPS Next 2Y6.82%
EPS Next 3Y5.8%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y3.51%
Revenue Next 3Y4.56%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IPAR Yearly Revenue VS EstimatesIPAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
IPAR Yearly EPS VS EstimatesIPAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 22.26, the valuation of IPAR can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of IPAR indicates a somewhat cheap valuation: IPAR is cheaper than 62.86% of the companies listed in the same industry.
IPAR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.85, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 19.13, IPAR is valued on the expensive side.
Based on the Price/Forward Earnings ratio, IPAR is valued a bit cheaper than the industry average as 62.86% of the companies are valued more expensively.
IPAR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.26
Fwd PE 19.13
IPAR Price Earnings VS Forward Price EarningsIPAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IPAR indicates a somewhat cheap valuation: IPAR is cheaper than 65.71% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IPAR is valued a bit cheaper than the industry average as 74.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.1
EV/EBITDA 11.5
IPAR Per share dataIPAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
IPAR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.18
PEG (5Y)1
EPS Next 2Y6.82%
EPS Next 3Y5.8%

5

5. Dividend

5.1 Amount

IPAR has a Yearly Dividend Yield of 2.78%. Purely for dividend investing, there may be better candidates out there.
IPAR's Dividend Yield is rather good when compared to the industry average which is at 5.56. IPAR pays more dividend than 82.86% of the companies in the same industry.
IPAR's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

The dividend of IPAR is nicely growing with an annual growth rate of 22.18%!
IPAR has been paying a dividend for at least 10 years, so it has a reliable track record.
IPAR has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)22.18%
Div Incr Years4
Div Non Decr Years4
IPAR Yearly Dividends per shareIPAR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

61.79% of the earnings are spent on dividend by IPAR. This is not a sustainable payout ratio.
The dividend of IPAR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP61.79%
EPS Next 2Y6.82%
EPS Next 3Y5.8%
IPAR Yearly Income VS Free CF VS DividendIPAR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
IPAR Dividend Payout.IPAR Dividend Payout, showing the Payout Ratio.IPAR Dividend Payout.PayoutRetained Earnings

INTERPARFUMS INC

NASDAQ:IPAR (8/20/2025, 3:31:09 PM)

113.95

+1.87 (+1.67%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners60.96%
Inst Owner Change2.14%
Ins Owners43.52%
Ins Owner Change-0.55%
Market Cap3.66B
Analysts84.44
Price Target168.3 (47.7%)
Short Float %6.62%
Short Ratio5.45
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend3
Dividend Growth(5Y)22.18%
DP61.79%
Div Incr Years4
Div Non Decr Years4
Ex-Date09-15 2025-09-15 (0.8)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.34%
Min EPS beat(2)-12.32%
Max EPS beat(2)15.01%
EPS beat(4)3
Avg EPS beat(4)3.64%
Min EPS beat(4)-12.32%
Max EPS beat(4)15.01%
EPS beat(8)5
Avg EPS beat(8)1.11%
EPS beat(12)9
Avg EPS beat(12)13.54%
EPS beat(16)13
Avg EPS beat(16)21.27%
Revenue beat(2)0
Avg Revenue beat(2)-2.32%
Min Revenue beat(2)-4.04%
Max Revenue beat(2)-0.59%
Revenue beat(4)0
Avg Revenue beat(4)-2.16%
Min Revenue beat(4)-4.04%
Max Revenue beat(4)-0.59%
Revenue beat(8)1
Avg Revenue beat(8)-1.64%
Revenue beat(12)3
Avg Revenue beat(12)-0.37%
Revenue beat(16)5
Avg Revenue beat(16)-0.08%
PT rev (1m)0%
PT rev (3m)1.85%
EPS NQ rev (1m)-1.24%
EPS NQ rev (3m)-0.88%
EPS NY rev (1m)0%
EPS NY rev (3m)0.75%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-1.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 22.26
Fwd PE 19.13
P/S 2.51
P/FCF 23.1
P/OCF 16.74
P/B 4.36
P/tB 7.23
EV/EBITDA 11.5
EPS(TTM)5.12
EY4.49%
EPS(NY)5.96
Fwd EY5.23%
FCF(TTM)4.93
FCFY4.33%
OCF(TTM)6.81
OCFY5.97%
SpS45.42
BVpS26.13
TBVpS15.75
PEG (NY)4.18
PEG (5Y)1
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 19.18%
ROCE 22.81%
ROIC 16.62%
ROICexc 19.82%
ROICexgc 28.81%
OM 19.21%
PM (TTM) 11.03%
GM 56.34%
FCFM 10.86%
ROA(3y)10.68%
ROA(5y)8.79%
ROE(3y)21.16%
ROE(5y)17.18%
ROIC(3y)17.76%
ROIC(5y)14.62%
ROICexc(3y)22.72%
ROICexc(5y)19.96%
ROICexgc(3y)35.6%
ROICexgc(5y)32.29%
ROCE(3y)23.62%
ROCE(5y)19.43%
ROICexcg growth 3Y6.05%
ROICexcg growth 5Y-2.44%
ROICexc growth 3Y8.08%
ROICexc growth 5Y4.09%
OM growth 3Y3.91%
OM growth 5Y5.52%
PM growth 3Y4.43%
PM growth 5Y6.05%
GM growth 3Y0.16%
GM growth 5Y0.24%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.61
Debt/EBITDA 0.64
Cap/Depr 210.07%
Cap/Sales 4.12%
Interest Coverage 44.75
Cash Conversion 70.78%
Profit Quality 98.45%
Current Ratio 2.96
Quick Ratio 1.69
Altman-Z 5.72
F-Score5
WACC8.74%
ROIC/WACC1.9
Cap/Depr(3y)438.01%
Cap/Depr(5y)567.12%
Cap/Sales(3y)5.93%
Cap/Sales(5y)7.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.63%
EPS 3Y22.78%
EPS 5Y22.27%
EPS Q2Q%-13.16%
EPS Next Y5.32%
EPS Next 2Y6.82%
EPS Next 3Y5.8%
EPS Next 5YN/A
Revenue 1Y (TTM)7.04%
Revenue growth 3Y18.2%
Revenue growth 5Y15.27%
Sales Q2Q%-2.42%
Revenue Next Year3.78%
Revenue Next 2Y3.51%
Revenue Next 3Y4.56%
Revenue Next 5YN/A
EBIT growth 1Y17.32%
EBIT growth 3Y22.82%
EBIT growth 5Y21.64%
EBIT Next Year11.55%
EBIT Next 3Y6.73%
EBIT Next 5YN/A
FCF growth 1Y246%
FCF growth 3YN/A
FCF growth 5Y20.52%
OCF growth 1Y45.26%
OCF growth 3Y16.2%
OCF growth 5Y19.66%